+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Organ Function Assays - Medical Devices Pipeline Assessment, 2019

  • ID: 4856567
  • Report
  • November 2019
  • 68 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Boditech Med Inc
  • Cornell University
  • Daxor Corp
  • DSX Therapeutics LLC
  • HepQuant Llc
  • Humedics GmbH
  • MORE
Organ Function Assays - Medical Devices Pipeline Assessment, 2019

Summary
The author's Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2019 provides an overview of Organ Function Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by The author's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Organ Function Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy
The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Organ Function Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boditech Med Inc
  • Cornell University
  • Daxor Corp
  • DSX Therapeutics LLC
  • HepQuant Llc
  • Humedics GmbH
  • MORE

1 Table of Contents

2 Introduction
2.1 Organ Function Assays Overview

3 Products under Development
3.1 Organ Function Assays - Pipeline Products by Stage of Development
3.2 Organ Function Assays - Pipeline Products by Territory
3.3 Organ Function Assays - Pipeline Products by Regulatory Path
3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date
3.5 Organ Function Assays - Ongoing Clinical Trials

4 Organ Function Assays - Pipeline Products under Development by Companies
4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development
4.2 Organ Function Assays - Pipeline Products by Stage of Development

5 Organ Function Assays Companies and Product Overview
5.1 Boditech Med Inc Company Overview
5.1.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 China Medical Technologies Inc (Inactive) Company Overview
5.2.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cornell University Company Overview
5.3.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Daxor Corp Company Overview
5.4.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 DSX Therapeutics LLC Company Overview
5.5.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 French National Institute of Health and Medical Research Company Overview
5.6.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.7 HepQuant Llc Company Overview
5.7.1 HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Humedics GmbH Company Overview
5.8.1 Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.9 Merck Millipore Corp Company Overview
5.9.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Myriad Genetics Inc Company Overview
5.10.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Proteome Sciences Plc Company Overview
5.11.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Radboud University Medical Centre Company Overview
5.12.1 Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
5.13 Schnellgen, Inc Company Overview
5.13.1 Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Organ Function Assays - Recent Developments
6.1 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters
6.2 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members
6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.4 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors
6.5 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results
6.6 Aug 01, 2019: CareDx reports second quarter 2019 results
6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.9 Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board
6.10 May 08, 2019: CareDx reports first quarter 2019 results
6.11 May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results
6.12 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
6.13 Apr 04, 2019: HepQuant’s Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117
6.14 Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results
6.15 Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018
6.16 Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager
6.17 Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test
6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
6.19 Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results
6.20 Jan 23, 2019: Proteome Sciences: Year-end trading update
6.21 Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
6.22 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away
6.23 Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
6.24 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
6.25 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
6.26 Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer
6.27 Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer
6.28 Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit
6.29 Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members
6.30 Nov 08, 2018: CareDx reports third quarter results
6.31 Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status
6.32 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved

7 Appendix
7.1 Methodology
7.2 About the author
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Organ Function Assays - Pipeline Products by Stage of Development
Table 2: Organ Function Assays - Pipeline Products by Territory
Table 3: Organ Function Assays - Pipeline Products by Regulatory Path
Table 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Table 5: Organ Function Assays - Ongoing Clinical Trials
Table 6: Organ Function Assays Companies - Pipeline Products by Stage of Development
Table 7: Organ Function Assays - Pipeline Products by Stage of Development
Table 8: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 27: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Glossary

List of Figures
Figure 1: Organ Function Assays - Pipeline Products by Stage of Development
Figure 2: Organ Function Assays - Pipeline Products by Territory
Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path
Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Figure 5: Organ Function Assays - Ongoing Clinical Trials

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boditech Med Inc
  • China Medical Technologies Inc (Inactive)
  • Cornell University
  • Daxor Corp
  • DSX Therapeutics LLC
  • French National Institute of Health and Medical Research
  • HepQuant Llc
  • Humedics GmbH
  • Merck Millipore Corp
  • Myriad Genetics Inc
  • Proteome Sciences Plc
  • Radboud University Medical Centre
  • Schnellgen, Inc
Note: Product cover images may vary from those shown
Adroll
adroll